Rekrutteringsfirma

Principal Scientist, Assay Development

Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger

Principal Scientist, Assay Development

Are you passionate about assay and method development, and do you thrive in a high-paced environment where you can influence how Y-mAbs work?

https://uhc.dk/wp-content/uploads/2023/03/Principal_Scientist_Assay_Development_ymab-1.mp4

As Principal Scientist, Assay Development at Y-mAbs, you will play a key role in defining the bioanalytical assay strategy for our pipeline of peptide/protein-based drug candidates. You will be responsible for the development and validation of non-clinical and clinical assays for PK, ADA and biomarkers/diagnostics incl. IHC.

With direct report to Chief Scientific Officer.

Your main tasks include, but are not limited to:

  • Establish overall development plans for assays of upcoming assays
  • Contracting with bioanalytical CROs (PK, ADA, DFA, and biomarker), including oversight, troubleshooting, and ensuring the right compound quality and documentation are available at CROs
  • Collaborate on the development and validation/qualification of preclinical assays (PK, ADA, and dose-formulation (DFA) assays), non-GLP, and GLP quality
  • Input to sampling time points in preclinical studies and PK calculation of PK data (non-GLP)
  • Development and validation of clinical PK, ADA, and biomarker assays (GLP/GCLP quality)

Your qualifications are more than 5 years of work experience in the biotechnology or pharmaceutical industry in cell therapy or Biologics. You have a solid scientific background in cellular biology and cell culture systems. You possess expertise in developing cell-based assays using analytical methods such as IHC, PK, ADA, etc. You understand regulatory requirements for method validation under GMP, have experience with defining specifications, and can interpret data. You are preferably fluent in Danish, written as spoken.

You have a degree-level qualification in Chemistry, Biochemistry, Pharmacology, Biology, or equivalent.

You are a dedicated, result-oriented team player who enjoys working in an innovative and passionate environment. You are proactive and self-driven, excellent at multi-tasking, have an entrepreneurial work approach, and can navigate a matrix organization across different departments and functions.

Y-mAbs offers an exciting career opportunity in a young, growing international company that fosters an open, trusting atmosphere. Y-mAbs provides significant professional and personal growth opportunities for its employees and is committed to helping employees balance work life and personal time.

Traveling: Approx. 10 days per year.

Domicile: In commuting distance of the office in Hørsholm.

For more details about the job or the company, please contact Director Life Science Gert Vium Andersen, Unique Human Capital on M: +45 42 95 08 83. All applications must be in English and are treated confidentially.


Information og data

Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".

Jobbet er oprettet på vores service den 6.3.2023, men kan have været deaktiveret og genaktiveret igen.

Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
  • Forsker

Statistik over udbudte jobs som forskere

Herunder ser du udviklingen i udbudte forsker over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.

Se flere statistikker her:
Statistik over udbudte forskere over tid

Dato Alle jobs som forskere
7. maj 2024 469
6. maj 2024 443
5. maj 2024 465
4. maj 2024 470
3. maj 2024 458
2. maj 2024 455
1. maj 2024 492
30. april 2024 512
29. april 2024 343
28. april 2024 381
27. april 2024 373
26. april 2024 372
25. april 2024 357
24. april 2024 346
23. april 2024 345
22. april 2024 331
21. april 2024 334
20. april 2024 337
19. april 2024 335
18. april 2024 332
17. april 2024 316
16. april 2024 316
15. april 2024 320
14. april 2024 319
13. april 2024 320
12. april 2024 328
11. april 2024 314
10. april 2024 307
9. april 2024 299
8. april 2024 299
7. april 2024 305